JAZZ FY 2009 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$11B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$128M+90.3% YoY

Gross Profit

$119M92.5% margin

Operating Income

$16M12.4% margin

Net Income

-$7M-5.3% margin

EPS (Diluted)

$-0.23

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$22M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$107M

Total Liabilities

$180M

Stockholders' Equity

-$73M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$128M	$68M	+90.3%
Gross Profit	$119M	$54M	+121.7%
Operating Income	$16M	-$170M	+109.4%
Net Income	-$7M	-$184M	+96.3%